Boston Scientific buys California stroke prevention startup for $220M

Boston Scientific Corp. announced Thursday that it has signed a $220 million agreement to buy Claret Medical Inc. and the system it has developed that reduces the risk of stroke during certain heart surgeries by 63 percent. Santa Rosa, California-based Claret received FDA approval last year to market the Sentinel Cerebral Embolic Protection System, which protects the brain during aortic valve replacements. Claret cites multiple studies showing that 4 percent of patients suffer from strokes after…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news